<PAGE>
Securities and Exchange Commission
Washington, D.C. 20549
FORM 8-A
FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PURSUANT TO SECTION 12(b) OR 12(g) OF THE
SECURITIES EXCHANGE ACT OF 1934
GO2PHARMACY, INC.
____________________________________
(Exact Name of Registrant as Specified in its Charter)
Florida 59-2600232
----------------- -------------------
(State or Other Jurisdiction of (IRS Employer Identification No.)
Incorporation or Organization)
6950 Bryan Dairy Road, Largo, Florida 33777
--------------------------------------------- ------------------
(Address of Principal Executive Offices) (Zip Code)
<TABLE>
<S> <C>
If this form relates to the registration If this form relates to the registration
of a class of securities pursuant to of a class of securities pursuant to
Section 12(b) of the Exchange Act Section 12(g) of the Exchange Act
and is effective pursuant to General and is effective pursuant to General
Instruction Instruction A.(d), check the following box. []
A.(c), check the following box: [X]
</TABLE>
Securities Act registration statement file number to which 333-92849
---------------
this form relates: (If applicable)
Securities to be registered pursuant to Section 12(b) of the Act:
Title of Each Class Name of Each Exchange on Which
To Be So Registered Each Class Is to Be Registered
------------------------ ----------------------------------
Common Stock, $.01 par value per share Boston Stock Exchange
---------------------------------------- ----------------------------------
__________________________________
Securities to be registered pursuant to Section 12(g) of the Act: None
<PAGE>
Item 1. Description of Registrant's Securities to Be Registered.
Reference is made to the Company's Registration Statement on Form SB-2
(Registration No.333-92849), and all amendments thereto, filed with the
Securities and Exchange Commission under the Securities Act of 1933, as amended.
A description of the Registrant's securities to be registered, as required by
Item 202 of Regulation S-K, is incorporated herein by reference to the section
entitled "Description of Capital Stock" in the Company's Preliminary Prospectus
forming a part of the Company's Registration Statement on Form SB-2, File
No.333-92849, and all amendments thereto, filed with the Securities Exchange
Commission on October 19, 2000.
Item 2. Exhibits.
Exhibit
Number Description of Document
------ -----------------------
A The "Description of Capital Stock" section of the Preliminary Prospectus
forming a part of the Registrant's Registration Statement on Form SB-2,
File No. 333-92849, and all amendments thereto, is incorporated herein
by reference, as referred to in Item 1.
1.1 Specimen of Certificate for Common Stock (Filed as Exhibit 4.1 to the
Registration Statement on Form SB-2, File No. 333-92849, and hereby
incorporated herein by reference).
2.1 Articles of Incorporation, as amended (Filed as Exhibits 3.1 and 3.3 to
the Registration Statement on Form SB-2, File No. 333-92849, and hereby
incorporated herein by reference).
2.2 By-Laws (Filed as Exhibit 3.2 to the Registration Statement on Form SB-
2, File No. 333-92849, and hereby incorporated herein by reference).
<PAGE>
SIGNATURE
Pursuant to the requirements of Section 12 of the Securities Exchange Act
of 1934, the registrant has duly caused this registration statement to be signed
on its behalf by the undersigned, thereto duly authorized.
GO2PHARMACY, INC.
Registrant
By:/s/ KOTHA S. SEKHARAM
-----------------------
Kotha S. Sekharam, President
Date: October 19, 2000
